Topiramate-induced neuromodulation of cortico–mesolimbic dopamine function: A new vista for the treatment of comorbid alcohol and nicotine dependence?
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Addictive Behaviors
- Vol. 29 (7) , 1465-1479
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Topiramate protects against glutamate- and kainate-induced neurotoxicity in primary neuronal–astroglial culturesEpilepsy Research, 2003
- Oligohydrosis and Hyperthermia: Pilot Study of a Novel Topiramate Adverse EffectJournal of Child Neurology, 2003
- Mecamylamine Modifies the Pharmacokinetics and Reinforcing Effects of AlcoholAlcohol, Clinical and Experimental Research, 2002
- Topiramate Titration and TolerabilityAnnals of Pharmacotherapy, 2001
- Topiramate in the Long‐Term Management of Refractory EpilepsyEpilepsia, 2000
- Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)Epilepsy Research, 1999
- Accumbal dopamine overflow after ethanol: Localization of the antagonizing effect of mecamylamineEuropean Journal of Pharmacology, 1997
- Relationship between alcohol and tobacco dependencies among alcoholics who smokeAddiction, 1995
- Smoking and Drinking: A Review of the LiteratureInternational Journal of the Addictions, 1990
- Alcoholism, cigarette smoking, coffee drinking and extraversion.Journal of Studies on Alcohol, 1976